Data in Tables 11-13 are based on the following analyses:
In ASD (1999) and SHDC (1998), what proportion of eligible1 patients were prescribed primary prophylaxis for PCP?
Data Source
Total
Male
Female
%
Treated/ Eligible
%
Treated/ Eligible
%
Treated/ Eligible
ASD
60
2,848/4,771
62
2,218/3,591
53
630/1,180
SHDC Site A
55
96/174
52
60/116
64
37/58
SHDC Site B
58
73/125
54
45/83
67
28/42
SHDC Site C
67
136/203
67
106/158
76
34/45
In ASD, a higher proportion of eligible males were prescribed PCP prophylaxis than females.
All SHDC sites had a greater proportion of eligible females prescribed prophylaxis compared with males.
Data from the SHAS and MOPTB studies were not available for this question.
1
Patients who have been previously diagnosed with PCP were excluded from this analysis because they are not eligible for primary prophylaxis.
